Roivant Sciences Ltd Ordinary Shares ROIV 深 滬
已收盤 09-19 16:00:00 美东时间
11.92
-0.080
-0.67%
華盛通- 最 高12.17
- 今 開12.03
- 成交量 1439.90万股
- 最 低 11.775
- 昨 收 12.00
- 總市值 83.92亿
- 52周最高 13.24
- 市盈率 靜 2.28
- 換手率 2.05%
- 52周最低 8.245
- 委 比 -92.40%
- 總股本 7.04亿
- 歷史最高 16.76
- 量 比 1.98
- 振 幅 3.29%
- 歷史最低 2.52
- 每 手 1
- 風險率 0.88%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Analysts Offer Insights on Healthcare Companies: Progyny (PGNY) and Roivant Sciences (ROIV)
Companies in the Healthcare sector have received a lot of coverage today as ana...
09-19 18:20
Roivant Sciences Subsidiary Acquired for $1.2 Billion
Roivant Sciences ( ($ROIV) ) just unveiled an update. Organon has announced pla...
09-18 19:57
Organon to acquire Dermavant for $1.2 billion
Organon (NYSE:OGN) said it will acquire Dermavant, which is a Roivant (ROIV) for $1.2 billion. The consideration has an upfront payment of $175 million and a $75 million milestone payment upon regulat...
09-18 19:44
Roivant Sciences Unveils Promising Pulmonary Hypertension Therapy
Roivant Sciences ( ($ROIV) ) has shared an announcement. Roivant Sciences Ltd. ...
09-10 19:52
Immunovant stock falls 8% amid Graves' disease program update
Immunovant (NASDAQ:IMVT) stock fell 8% Monday after it reported data from a Phase 2a study of batoclimab in the treatment of Graves’ disease, adding the FDA has cleared it to begin a pivotal trial of ...
09-10 05:18
Roivant Sciences Reveals Promising Batoclimab Trial Results
Roivant Sciences ( ($ROIV) ) just unveiled an announcement. Roivant Sciences Lt...
09-09 20:17
Roivant Sciences (ROIV) Receives a Buy from H.C. Wainwright
In a report released today, Douglas Tsao from H.C. Wainwright maintained a Buy ...
08-19 18:36
Evaluating Roivant Sciences: Insights From 6 Financial Analysts
Roivant Sciences (NASDAQ:ROIV) has been analyzed by 6 analysts in the last thre...
06-18 23:00
Cantor Fitzgerald Reiterates Overweight on Roivant Sciences
Cantor Fitzgerald analyst Louise Chen reiterates Roivant Sciences (NASDAQ:ROIV) with a Overweight.
06-18 22:07
Roivant Sciences' (NASDAQ:ROIV) Performance Raises Some Questions
Even though Roivant Sciences Ltd. (NASDAQ:ROIV) posted strong earnings recently...
06-06 19:41
